Key result
Triple arterial minimally invasive direct coronary artery bypass grafting was successfully performed for multivessel coronary disease, with all grafts showing normal flow at two months.
Case Report (n=1)
No
Triple arterial minimally invasive direct coronary artery bypass grafting (MIDCAB) without cardiopulmonary bypass is a feasible technique for achieving complete revascularization in patients with multivessel coronary artery disease.
Answers are grounded in this paper and cite their sources.
Supports technical feasibility of triple arterial MIDCAB in multivessel disease; leaves open durability and generalizability pending larger studies.
Minimally invasive direct coronary artery bypass grafting (MIDCAB) has considerable benefits over the conventional coronary artery bypass grafting procedure. This case report presents the MIDCAB procedure in a multivessel coronary disease using triple arterial grafts and four arterial anastomoses. The initial anastomosis was made between the left intrathoracic mammary artery (LIMA) and the radial artery (RA), as an end-to-side "T" graft. Next, the RIMA was used to left anterior descending anastomosis. The first obtuse marginal (OM1) branch was grafted to allow LIMA-OM1 side-to-side anastomosis. Then, with the diagonal branch (Dg) opened, the formation of a "jumping" anastomosis was made using LIMA-OM1-Dg. The posterior descending artery (PDA) was used to create a LIMA-RA-PDA.
No takes yet. Share an insight, caveat, or question.
Grujic et al. (2025) conducted a case report in Multivessel coronary artery disease (n=1). Triple arterial minimally invasive direct coronary artery bypass grafting (MIDCAB) was evaluated on Graft patency. Triple arterial minimally invasive direct coronary artery bypass grafting was successfully performed for multivessel coronary disease, with all grafts showing normal flow at two months.
Synapse has enriched 10 related papers. Consider them for comparative context: